Rohan Palekar - Mar 2, 2022 Form 3 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
Director
Signature
/s/ Sean Smith, as Attorney-in-Fact for Rohan Palekar
Stock symbol
NLTX
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
3
Date filed
3/4/2022, 04:28 PM
Previous filing
Feb 22, 2022
Next filing
May 16, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney